JP2023510258A5 - - Google Patents
Info
- Publication number
- JP2023510258A5 JP2023510258A5 JP2022541814A JP2022541814A JP2023510258A5 JP 2023510258 A5 JP2023510258 A5 JP 2023510258A5 JP 2022541814 A JP2022541814 A JP 2022541814A JP 2022541814 A JP2022541814 A JP 2022541814A JP 2023510258 A5 JP2023510258 A5 JP 2023510258A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025175228A JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959829P | 2020-01-10 | 2020-01-10 | |
| US62/959,829 | 2020-01-10 | ||
| PCT/US2021/012826 WO2021142360A1 (en) | 2020-01-10 | 2021-01-08 | Stable cyclodextrin free carfilzomib formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175228A Division JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510258A JP2023510258A (ja) | 2023-03-13 |
| JP2023510258A5 true JP2023510258A5 (https=) | 2024-01-16 |
| JPWO2021142360A5 JPWO2021142360A5 (https=) | 2024-01-16 |
Family
ID=74626106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541814A Pending JP2023510258A (ja) | 2020-01-10 | 2021-01-08 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
| JP2025175228A Pending JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175228A Pending JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250345384A1 (https=) |
| EP (1) | EP4087538A1 (https=) |
| JP (2) | JP2023510258A (https=) |
| CN (1) | CN115279339A (https=) |
| WO (1) | WO2021142360A1 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340736A (en) | 1991-05-13 | 1994-08-23 | The President & Fellows Of Harvard College | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| AU4499697A (en) | 1996-09-13 | 1998-04-02 | New York University | Method for treating parasitic diseases with proteasome inhibitors |
| TWI674262B (zh) * | 2011-01-10 | 2019-10-11 | 美商英菲尼提製藥股份有限公司 | 製備異喹啉酮之方法及異喹啉酮之固體形式 |
| PH12012502259A1 (en) * | 2012-05-08 | 2019-07-03 | Onyx Therapeutics Inc | Cylodextrin complexation methods for formulating peptide proteasome inhibitors |
| EP2914296B2 (en) * | 2012-11-01 | 2021-09-29 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
| PT2865391T (pt) * | 2013-10-22 | 2017-12-22 | Medac Ges Für Klinische Spezialpräparate Mbh | Processo para a produção de uma composição farmacêutica liofilizada com um conteúdo de mitomicina c |
| WO2015198257A1 (en) * | 2014-06-26 | 2015-12-30 | Intas Pharmaceuticals Ltd. | Stable carfilzomib injection |
| CA2966288A1 (en) * | 2014-10-30 | 2016-05-06 | Big Dna Ltd | Combination therapy |
| WO2016116882A2 (en) * | 2015-01-23 | 2016-07-28 | Leiutis Pharmaceuticals Pvt Ltd | Novel compositions of carfilzomib |
| TWI759301B (zh) * | 2016-05-24 | 2022-04-01 | 美商安美基公司 | 聚乙二醇化卡非佐米化合物 |
-
2021
- 2021-01-08 JP JP2022541814A patent/JP2023510258A/ja active Pending
- 2021-01-08 WO PCT/US2021/012826 patent/WO2021142360A1/en not_active Ceased
- 2021-01-08 US US17/810,136 patent/US20250345384A1/en active Pending
- 2021-01-08 EP EP21705680.3A patent/EP4087538A1/en active Pending
- 2021-01-08 CN CN202180020091.3A patent/CN115279339A/zh active Pending
-
2025
- 2025-10-17 JP JP2025175228A patent/JP2026016486A/ja active Pending